We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+2.39%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$18.8B
AUM Growth
Cap. Flow
+$18.6B
Cap. Flow %
98.77%
Top 10 Hldgs %
14.87%
Holding
1,277
New
1,254
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$355M
2
AAPL icon
Apple
AAPL
+$344M
3
CVX icon
Chevron
CVX
+$323M
4
JPM icon
JPMorgan Chase
JPM
+$296M
5
XOM icon
ExxonMobil
XOM
+$285M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 15.07%
2 Financials 12.69%
3 Technology 11.8%
4 Energy 9.95%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALOT icon
1251
AstroNova
ALOT
$225M
$2K ﹤0.01%
+186
New +$1.95K
LXP icon
1252
LXP Industrial Trust
LXP
$3.53B
$2K ﹤0.01%
+40
New +$2.47K
LION
1253
DELISTED
Fidelity Southern Corporation
LION
$1K ﹤0.01%
+101
New +$1.2K

Similar funds

Axa's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Axa, which disclosed 1,277 positions worth $18.8B. Its ten largest holdings account for 15% of the portfolio.

Its largest position is Pfizer: 12,852,527 shares worth $342M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, followed by Financials and Technology.

  • Axa's largest Q2 2013 buy was Pfizer: 12,852,527 shares worth $342M.
  • Axa's ten largest holdings make up 15% of its $18.8B portfolio in Q2 2013.
  • Axa disclosed 1,277 positions in Q2 2013, its first 13F filing on record.

Based on Axa's 13F filing for Q2 2013, filed 12 Aug 2013.